Brendan Smith

Stock Analyst at TD Cowen

(2.21)
# 2,848
Out of 5,044 analysts
8
Total ratings
60%
Success rate
8.07%
Average return

Stocks Rated by Brendan Smith

West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $283.49
Upside: +23.46%
Simulations Plus
Sep 30, 2025
Initiates: Hold
Price Target: $16
Current: $18.31
Upside: -12.62%
Ginkgo Bioworks Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $3$10
Current: $12.74
Upside: -21.51%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $59$65
Current: $65.40
Upside: -0.61%
Novavax
May 13, 2024
Maintains: Hold
Price Target: $5$10
Current: $8.52
Upside: +17.37%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $39.55
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $16.92
Upside: -